Loading market dashboard
Frontline Ltd.
FROEnergyNYSECY
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Shipping ETFs are riding on elevated freight rates as Middle East disruptions reshape logistics, with BWET SEA posting strong 2026 gains.
Frontline is benefiting from an exceptionally strong tanker-rate environment, driving record profitability and robust cash flow. Q1 2026 delivered adjusted EPS of $1.55, $714.2M revenue, and a $1.55/share dividend, with forward fixtures indicating even higher earnings in Q2. FRO trades at a compressed multiple (trailing PE 8.5x, forward PE 4.5x) despite near-peak earnings, supporting a buy rating.
President Trump told Fox Business this week he would hold the line on Iran sanctions.
On May 27, 2026, Frontline PLC (FRO) shares fell 3.0% today, trading at $35.46. This price movement comes amid a 52-week range of $16.25 to $39.89, highlighting
Frontline plc (FRO) Q1 2026 Earnings Call Transcript
Frontline NYSE: FRO reported what Chief Executive Officer Lars Barstad called the company's most profitable quarter since 2004, as tanker markets were reshaped by the effective closure of the Strait of Hormuz and shifting global oil trade patterns.
CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced positive results from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) non-classical mutations (NCMs). These data will be presented by Julia Rotow, M.D., Clinical Director, Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, at the 2026 American Society of Clinical Oncology® (ASCO®) Annual Meeting on Saturday, May 30, 2026, 1:15 PM-2:45 PM CDT.
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Continuing a decades-long commitment to driving innovation in public safety, emergency response and community resilience, Verizon today announced the winner of its first-ever Verizon Frontline App Developer Challenge.
Persistent inflation, higher oil prices, and geopolitical tensions continue supporting income-oriented sectors tied to energy and select financials. Tanker shipping and refining companies can benefit from disrupted trade routes, tighter fuel markets, and stronger cash flow during energy market dislocations. Higher-rate financials and cash-generating companies may provide defensive income opportunities as investors prepare for continued volatility surrounding inflation and midterm elections.
On May 11, 2026, Frontline PLC (FRO) shares fell 3.4%, closing at $38.15. The stock has seen significant movement over the past year, with a 52-week range betwe
Small-cap stocks may lead after Fed rate cuts, giving individual investors an edge Wall Street is too big to use.
Program Enters Final Stage of Dose Optimization Data Continue to Demonstrate Strong Clinical Activity and Favorable Safety Across an Expanding Frontline Dataset SEATTLE, WA / ACCESS Newswire / May 6, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO) today reported new clinical results from its RAINIER frontline acute myeloid leukemia (AML) trial. The Company is on track to complete the Phase 1b dose-optimization trial and select the recommended Phase 2 dose (RP2D) this year.
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.74%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.
Frontline is the largest listed pure-play crude oil tanker company, operating a young and efficient fleet of 81 vessels. Recent VLCC rate spikes above $100k/day reflect a multi-year structural trend, not a transient event, supporting FRO's positive outlook. Global tanker supply is constrained by aging fleets, limited newbuild slots, and tankers tied up in the shadow fleet, tightening effective capacity.
Zovegalisib + atirmociclib + AI selected as triplet regimen for frontline development Compelling efficacy and tolerability data for zovegalisib triplet in median 3L patients 44% ORR in heavily pre-treated, CDK4/6-experienced patients (median third-line); ORR is similar across kinase and non-kinase PIK3CA mutations Phase 3 frontline trial in endocrine sensitive patients expected to initiate in early 2027, subject to regulatory feedback Supply agreement in place with Pfizer to supply atirmociclib for the Phase 3 frontline trial Relay Therapeutics to host a conference call today, April 27, at 8:30am ET CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced plans to move zovegalisib + atirmociclib, Pfizer's investigational, potential first-in-class CDK4 inhibitor, into Phase 3 development for frontline patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer.
Wayne, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- Frontline Education, a leading provider of administration software purpose-built for K-12, today announced a series of advancements that accelerate its AI innovation across K-12—building momentum in how the company is applying AI to support school systems in the work ahead.
CAMBRIDGE, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced multiple presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting from May 29 – June 2, 2026, in Chicago.
On April 15, 2026, Frontline PLC (FRO) shares rose 3.9%, bringing the current price to $35.49. Over the past year, the stock has shown remarkable resilience, wi
Investors have experienced the market's recent choppiness and are growing concerned the easy gains from low energy costs are evaporating.
A.P. Moller-Maersk (OTCMKTS:AMKBY - Get Free Report) and Frontline (NYSE: FRO - Get Free Report) are both transportation companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends and profitability. Dividends A.P. Moller-Maersk pays an annual dividend of $0.20
GIG HARBOR, Wash., April 07, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company”) today highlighted Aria Protocol's partnership with RESCENE for the release of their new single “Busy Boy.
Oil prices just delivered their biggest one-day jump in six years.
Frontline, the world's largest operator of VLCC oil tankers, is positioned to benefit from the ongoing Strait of Hormuz crisis. As VLCC charter rate spike, Frontline, with its high amount of operating leverage, is poised to experience a big jump in profitability this year.
Campaign recognized for its human-centered approach to AI and K-12 collaboration Campaign recognized for its human-centered approach to AI and K-12 collaboration
Frontline plc operates in the highly volatile energy shipping sector, with dual listings on the NYSE and Oslo for FX diversification. Investing in FRO requires abandoning traditional value investing and focusing on commodity cycles, sector trends, and shorter-term forecasting. Shipping sector investments demand comfort with prolonged downturns and a willingness to hold through extended cyclical lows.
Frontline is rated a "Buy," supported by surging VLCC rates, robust technicals, and strong earnings momentum. Q4 revenue rose 47% YoY to $625 million, with adjusted profits jumping to $230.4 million, driven by higher TCE earnings and lower expenses. FRO locked in the Q1 spot, TCE rates at elevated levels, forecasts over 100% EPS growth, and offers a 12.8% forward dividend yield.
Crude oil stocks stand to gain from surging prices and supply chain disruptions, offering investors defensive, short-term tactical buying opportunities. The goal of defensive trading is to preserve capital and mitigate risk until more favorable market conditions return. Explore the ‘Strong Buy' recommendations in this article, which are up an average +60% YTD, trade at a discount, and offer strong fundamentals that may benefit from the crude oil trade.
The de facto closure of the Strait of Hormuz amid the Iran conflict sent oil prices surging, before a dramatic reversal when President Donald Trump said the conflict might end. Stocks fell as oil prices surged amid concerns that rising energy costs could fuel inflation, reducing the odds of near-term interest rate cuts. Companies that stand to benefit from oil supply disruptions include integrated energy giants and companies involved in oil exploration, production, and shipping.
Oil prices have surged dramatically in early 2026, driven by the escalating Iran conflict and fears of Strait of Hormuz disruption.
We ran a screen on dividend stocks with yields above 4%, trading on U.S. exchanges, with market caps of at least $500 million, ranked by 2026 price performance.
